Overexpression of cortactin/CTTN is linked to metastatic disease in head and neck cancer, breast cancer, oesophageal cancer, hepatocellular carcinoma, melanoma and colorectal cancer32–39. This evidence concerns the gene CTTN and head and neck cancer.